Profusa, Inc. (PFSA): Submission of Matters to a Vote of Security Holders
Profusa, Inc. (PFSA) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders. On September 18, 2026, the Company held a Special Meeting of Stockholders (the “Meeting”), which was convened virtually at www.virtualshareholdermeeting.com/PFSA2026SM , pursuant to notice duly given. Definitive proxy
How this was made
The 30-second read
Why it matters
The proposal, if executed, could alter share count and price perception, creating trading opportunities.
Market read
Primary relevance to PFSA shareholders; minimal broader market effect.
What to watch
Board discretion on split ratio and timing creates uncertainty; regulatory approval may be required.
Background
Profusa filed an 8‑K detailing a special meeting where shareholders voted on a reverse split proposal.
Ticker impact
SEC 8‑K reports shareholders voted on a reverse stock split proposal, indicating potential future dilution and price impact.
Potential short‑term upside if market anticipates a split; downside risk if split is delayed or rejected.
Reverse splits are rare for micro‑caps and can trigger speculative buying, but execution is discretionary.
Market effects
May influence other micro‑cap biotech stocks that could consider similar capital structure moves.
Limited to U.S. OTC/NASDAQ micro‑cap segment.
Low; primarily affects PFSA shareholders.
Counterpoint
Investors could short PFSA anticipating that the split will not materialize and cause dilution of existing holdings.
Key entities
- CompanyProfusa, Inc.
Biotech firm listed on NASDAQ under PFSA.
- ExecutiveJack Stover
Chief Executive Officer who signed the filing.